Ocular syphilis is re-emerging in Europe and is often first detected by ophthalmologists, with acute placoid chorioretinitis being a common manifestation. Medscape News UK
Tag: News
Gene Therapy Shows Signal for Improving Retinal Function
Patients with potentially blinding retinitis pigmentosa recover retinal sensitivity 3 years after receiving a gene therapy targeting the causal mutation. Medscape Medical News
Aflibercept 8 mg Shows Gains in Previously Untreated AMD
Patients with age-related macular degeneration who are new to treatment experience gains in vision and anatomical markers 6 months after starting high-dose aflibercept, a study shows. Medscape Medical News
Study Supports Earlier Start for Geographic Atrophy Drug
Patients who start on pegcetacoplan for geographic atrophy at the outset of a 4-year study retain almost three times more macular tissue than those who wait to begin treatment. Medscape Medical News
AREDS Vitamins Show No Effect in Geographic Atrophy
An analysis of pivotal phase 3 trials shows supplements to arrest age-related macular degeneration have no effect on geographic atrophy. Medscape Medical News
Eye Surgery Follow-Ups: Does a Day Make a Difference?
Follow-up visits on the day of surgery may offer patients greater flexibility without sacrificing safety, a study shows. Medscape Medical News
Hypoglycemia Tied to Risk for Diabetic Retinopathy
Low blood glucose is linked to worsening eye disease in a new study. Medscape Medical News
Poll: Are You Practicing Medicine Abroad? Would You Like To?
Medscape’s editors are investigating what is needed to practice medicine in various countries around the world, and we want to hear from you! Medscape Reader Polls
US FDA Declines to Approve Outlook Therapeutics’ Eye Disease Drug, Shares Plummet
Outlook Therapeutics said on Thursday the U.S. health regulator has again declined to approve its experimental eye drug, citing a lack of substantial evidence of… Reuters Health Information
Diabetic Macular Edema: Second-Gen Anti-VEGFs Lead the Way
Medscape Medical News
Pill That Slows Aging? Meds May Boost Health Span
Metformin, rapamycin, and senolytics show multifaceted effects on aging biology that could transform how clinicians approach chronic disease prevention. Medscape Medical News
AMD Light Therapy Restores Vision Gains Post-Treatment Pause
A tabletop light therapy device led to vision improvements over 4.5 years and a long pause between treatments in people with dry age-related macular degeneration. Medscape Medical News
Simple, Noninvasive Eye Tracking May Flag Cognitive Decline
Naturalistic gaze patterns appear to be a simple, noninvasive, and reliable indicator of cognitive decline, new research suggests. Medscape Medical News
New Anti-VEGF Agents Extend Dosing Intervals in Wet AMD
New anti-VEGF agents for wet age-related macular degeneration can extend injection intervals to 3-5 months but may increase inflammation risk, prompting calls for tailored treatment plans. Medscape Medical News
Study Counters Others on GLP-1, Diabetic Retinopathy Link
An observational study of 160,000 patients with diabetes taking GLP-1 drugs finds no heightened risk for retinopathy complications. Medscape Medical News
Study Counters Others on GLP-1, Diabetic Retinopathy Link
An observational study of 160,000 patients with diabetes taking GLP-1 drugs finds no heightened risk for retinopathy complications. Medscape Medical News
As Copay Aid Recedes, Retina Treatment ‘Unsustainable’
A new study finds cuts in copay assistance for retina injections are harming lower-income communities and leading to poorer vision outcomes. Medscape Medical News
Port Delivery System Outperforms Injections for DME
In patients with diabetic macular edema in both eyes, the port delivery system in one eye achieves a superior anatomical response than intravitreal injection the other, a new study shows. Medscape Medical News
Retina Tear Raises Detachment Risk After Cataract Surgery
Delaying cataract surgery 6 months or more after laser for retina tears reduces the risk for retinal detachment by half, a new study shows. Medscape Medical News
Veligrotug Shows Promise for Treating Thyroid Eye Disease
The THRIVE and THRIVE-2 clinical trials showed significant improvements in proptosis and diplopia in active as well as chronic thyroid eye disease, earning FDA Breakthrough Therapy designation. Medscape Medical News